Anno Nuovo? Non per l’American Heart Association e per l’American Diabetes Association. Cui Prodest l’immobilismo?

AHA e ADA, due autorevoli fonti di informazione della Medicina statunitense, continuano ad ignorare le mie ripetute segnalazioni sulla esistenza dei Reali Rischi Congeniti di CAD e T2DM, unico strumento per realizzare su vasta scala, clinicamente e con poca spesa (Terapia Quantistica Mitocondriale Ristrutturante, la Prevenzione Pre-Primaria e Primaria di CVD e T2DM.

A chi serve questo tanatofilo immobilismo?

Ecco la mia risposta alla mail appena giuntami da AHA e ADA che potete leggere in fondo al post:

Dear Colleagues of AHA and ADA,

I invite you to update in your own interest, and in that of your loved ones and the rest of humanity, as I wrote you previously unheard,

Study the Constitution-dependent, Inherited Real Risks of CAD and DM, as follow:



1)  Sergio Stagnaro and Simone Caramel (2012) Quantum Biophysical Semeiotics Microcirculatory Theory of Arteriosclerosis, Journal of Quantum Biophysical Semeiotics, first version,

2) Sergio Stagnaro, Use of multiple markers and improvement of the prediction model for cardiovascular mortality,, 21 May, 2008

3)   Stagnaro Sergio.    CAD Inherited Real Risk, Based on Newborn-Pathological, Type I, Subtype B, Aspecific, Coronary Endoarteriolar Blocking Devices. Diagnostic Role of Myocardial Oxygenation and Biophysical-Semeiotic Preconditioning. International Atherosclerosis Society., 29 April, 2009, now in rete

   4) Sergio Stagnaro   (29 May 2008) Bedside Recognizing CAD Inherited Real Risk and silent CAD with Biophysical Semeiotics.

5) Sergio Stagnaro  Bed-side biophysical semeiotic recognizing CAD “inherited real risk” and overt CAD, event silent. l: (18 October 2003).,

6) Sergio Stagnaro Assessing NK cell compartment in individuals with CAD Inherited Real Risk. Immunity & Aging, (14 May 2007),  

7) Sergio Stagnaro.  Bedside Biophysical-Semeiotic Recognizing CAD Real Risk and silent CAD. Journal Review,

8)  Sergio Stagnaro.  A Clinical Biophysical-Semeiotic Contribution reliable in prompt recognizing CAD, even silent. BMC.Cardiovascular Disorders, 2005,

9)    Sergio Stagnaro. Without CAD Inherited Real Risk, All Environmental Risk Factors of CAD are innocent Bystanders. Canadian Medical Association Journal.CMAJ, 14 Dec 2009, 

10)  Stagnaro Sergio. Role of Coronary Endoarterial Blocking Devices in Myocardial Preconditioning – c007i. Lecture, V Virtual International Congress of Cardiology, 2007.

11)  Sergio Stagnaro.  A Clinical Method far better than Blood Cell Count in CAD Primary Prevention., 2005, 

12)  Sergio Stagnaro.    Biophysical Semeiotics is really useful in order to bed-side recognizing heart ischaemic disease, even before its onset, i.e., real risk of coronary artery disease. BMC. Cardiovascular Diseases, 2004,

13) Stagnaro Sergio. Bedside Evaluation of CAD biophysical-semeiotic inherited real risk under NIR-LED treatment. EMLA Congress, Laser Helsinki August 23-24, 2008. “Photodiagnosis and photodynamic therapy”, Elsevier, Vol. 5 suppl 1 august 2008 issn 1572-1000

14) Sergio Stagnaro    Biophysical-Semeiotic Diagnosing Cad “real” risk, as well as pre-clinical and clinical CAD., (12 September 2003)

15)   Sergio Stagnaro   Bedside Biophysical Semeiotic Evaluation of Acute Phase Proteins. Ann Family Med. 2008, 

16)    Sergio Stagnaro.    EBM “and” Single Patient Based Medicine, Medical News today, 2007,

17) Sergio Stagnaro. Inherited Real Risk of CAD and Cancer,, 2008,

18) Sergio Stagnaro (2012).  I Segni di Caotino* e di Gentile** nella Diagnosi di Reale Rischio Congenito di CAD e di Infarto Miocardico, ancorché iniziale o silente. Fisiopatologia e Terapia. Lectio Magistralis. III Convegno della SISBQ, 9-10 Giugno 2012, Porretta Terme (Bologna).; English version:

19) Stagnaro Sergio. Reale Rischio Semeiotico Biofisico. I Dispositivi Endoarteriolari di Blocco neoformati, patologici, tipo I, sottotipo a) oncologico, e b) aspecifico. Ediz. Travel Factory,, Roma, 2009.

20) Simone Caramel and Sergio Stagnaro (2012).   Vascular calcification and Inherited Real Risk of lithiasis. Front. In Endocrin.  3:119. doi: 10.3389/fendo.2012.00119  [MEDLINE].

21) Sergio Stagnaro and Simone Caramel.  The Key Role of Vasa Vasorum Inherited Remodeling in QBS Microcirculatory Theory of Atherosclerosis. Frontiers in Epigenomics and Epigenetics.  [MEDLINE]

22) Sergio Stagnaro (2013).   Two Clinical Evidences corroborating Microcirculatory QBS Theory of Atherosclerosis.Lectio Magistralis, IV Meeting of Quantum Biophysical Semeiotics International Society, May 4-5, 2013, Porretta Terme, Bologna, Auditorium, Hotel Santoli. Journal of QBS,

25) Sergio Stagnaro (2013).   Abdominal Aortic Aneurism Inherited Real Risk: Patho-Physiology, Quantum-Biophysical-Semeiotic Symptomatology, Diagnosis and Therapy. Journal of Quantum Biophysical Semeiotics.

26) Sergio Stagnaro, Simone Caramel. Inherited Real Risk of Coronary Artery Disease: pathophysiology, diagnosis and primary prevention. Epidemiology and Cardiovascular Prevention. Brief Communication. 8th International Congress of Cardiology in the internet. Published: 28 October 2013. FAC Federaciòn Argentina de Cardiologia   – PDF

27)  Sergio Stagnaro. CAD Inherited Real Risk In Preventing Myocardial Infarct., 13 September, 2010.

28) Sergio Stagnaro. Reale Rischio Congenito di Infarto miocardio. Fondamentali Aspetti Teorici, 2014.,

29) Sergio Stagnaro. Il Reale Rischio Congenito di Infarto Miocardico: Fisiopatologia, Diagnosi e Terapia. Il Ruolo centrale svolto dal Diabete Mellito Tipo 2 Stagnaro e

30) Pyatakovich F.A., Stagnaro S.,   Caramel S., Yakunchenko T.I., Makkonen K.F., Moryleva O.N.  Background Millimeter Radiation Influence in Cardiology on patients with metabolic and pre-metabolic  syndrome. Journal of Infrared and Millimeter Waves, , Shanghai, China

31)  Simone Caramel (2010). Coronary Artery Disease and Inherited Real Risk of  CAD.  Journal of Quantum Biophysical Semeiotics.

32) Sergio Stagnaro, Simone Caramel. Inherited Real Risk of Coronary Artery Disease: pathophysiology, diagnosis and primary prevention.Epidemiology and Cardiovascular Prevention. Brief Communication. 8th International Congress of Cardiology in the internet. Published: 28 October 2013. FAC Federaciòn Argentina de Cardiologia   – PDF

33) Sergio Stagnaro and Simone Caramel. The Inherited Real Risk of Coronary Artery Disease, Nature PG., European Journal of Clinical Nutrition volume 67, page 683 (2013), [MEDLINE]

34) Simone Caramel, Marco Marchionni  and Sergio Stagnaro (2014). The Glycocalyx Bedside Evaluation Plays A Central  Role in Diagnosing Type 2 Diabetes Mellitus and in its Primary Prevention. Treatment Strategies – Diagnosing Diabetes, Cambridge Research Centre, Volume 6 Issue 1, Pg 41-43.

35) Mario Siniscalchi, Simone Caramel, Sergio Stagnaro (2016).Quando il fonendoscopio aiuta il cardiologo. Cuore e Vasi. Anno XXXVII • N. 3-4/2015, dicembre. Pg.15.

36) Sergio Stagnaro (2019). ATS Constitution-Dependent, Inherited Real Risk is the conditio sine qua non of coronary disorder, including AMI.   European Society of Cardioloy, ESC, Oxford Academic, European Heart Journal

37) Sergio Stagnaro (2016).  We can defeat CAD with or without predisposition to AMI. April 20, 2016. Comment on JAMA website.

38) Sergio Stagnaro (2019). ATS Constitution-Dependent, Inherited Real Risk is the conditio sine qua non of coronary disorder, including AMI.  European Heart Journal, Comment, 1 November 2019.

  I’m awaiting your critical answer.


  Dr Sergio Stagnaro

Sergio Stagnaro MD

Via Erasmo Piaggio 23/8,

16039 Riva Trigoso (Genoa) Italy

Phone 0390-0185-42315

Founder of Quantum Biophysical Semeiotics,

Honorary President of International Society of

Quantum Biophysical Semeiotics (SISBQ) Il 31/12/2020 21:09, Know Diabetes by Heart ha scritto:

Having trouble viewing this email? View it in your browser.

MANAGING CV RISK AND RENAL RISK IN PATIENTS WITH T2D Patients with T2D and CKD have a very high risk of CV events. Listen as Dr. Jorge Plutzky and Dr. Neha Pagidipati discuss new therapies to manage cardiovascular and renal risk in patients with T2D. Their discussion is based on new science presented during AHA Scientific Sessions 2020. LISTEN FOR FREE NEW WEBINAR AVAILABLE!

MANGEMENT OF RISK FACTORS IN PATIENTS WITH CVD AND T2D The American Heart Association, the American Diabetes Association and The American Society for Preventive Cardiology have partnered together to discuss Management of Risk Factors in Patients with Cardiovascular Disease and type 2 diabetes. Hear from Dr. Harold Bays and Jane Reusch as they discuss controlling individual cardiovascular risk factors in preventing or slowing ASCVD in people with diabetes. LAUNCH HERE

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: